Jennison Associates
EXAS

Jennison Associates’s Exact Sciences EXAS Stock Holding History

Jennison Associates’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-306,196
Closed -$16.8M – 604
2025
Q3 		$16.8M Sell
306,196
-199,069
-39% -$9.95M 0.01% 339
2025
Q2 		$26.8M Sell
505,265
-193,423
-28% -$9.83M 0.02% 295
2025
Q1 		$30.2M Sell
698,688
-64,048
-8% -$3.24M 0.02% 277
2024
Q4 		$42.9M Sell
762,736
-121,923
-14% -$7.59M 0.03% 251
2024
Q3 		$60.3M Sell
884,659
-30,775
-3% -$1.74M 0.04% 202
2024
Q2 		$38.7M Buy
915,434
+281,805
+44% +$15.5M 0.02% 252
2024
Q1 		$43.8M Sell
633,629
-727,288
-53% -$46M 0.03% 241
2023
Q4 		$101M Buy
1,360,917
+659,235
+94% +$43.2M 0.08% 107
2023
Q3 		$47.9M Buy
701,682
+250,501
+56% +$21.3M 0.04% 181
2023
Q2 		$42.4M Buy
451,181
+12,247
+3% +$955K 0.03% 213
2023
Q1 		$29.8M Buy
+438,934
New +$28.2M 0.03% 270
2021
Q4 		– Sell
-159,731
Closed -$15.2M – 681
2021
Q3 		$15.2M Sell
159,731
-111,634
-41% -$11.8M 0.01% 404
2021
Q2 		$33.7M Buy
271,365
+49,271
+22% +$5.88M 0.02% 287
2021
Q1 		$29.3M Buy
+222,094
New +$30.4M 0.02% 303
2020
Q2 		– Sell
-1,435,861
Closed -$83.3M – 651
2020
Q1 		$83.3M Sell
1,435,861
-4,191,138
-74% -$340M 0.1% 92
2019
Q4 		$520M Buy
5,626,999
+202,478
+4% +$17.8M 0.53% 45
2019
Q3 		$490M Buy
5,424,521
+2,120,591
+64% +$242M 0.52% 46
2019
Q2 		$390M Buy
3,303,930
+2,261,394
+217% +$228M 0.39% 49
2019
Q1 		$90.3M Sell
1,042,536
-2,114
-0.2% -$180K 0.09% 128
2018
Q4 		$65.9M Sell
1,044,650
-108,336
-9% -$7.44M 0.07% 165
2018
Q3 		$91M Buy
1,152,986
+186,726
+19% +$12.2M 0.08% 160
2018
Q2 		$57.8M Buy
966,260
+4,096
+0.4% +$220K 0.06% 245
2018
Q1 		$38.8M Buy
962,164
+443,575
+86% +$21.6M 0.04% 291
2017
Q4 		$27.2M Buy
518,589
+374,078
+259% +$20M 0.03% 354
2017
Q3 		$6.81M Buy
144,511
+266
+0.2% +$10.7K 0.01% 495
2017
Q2 		$5.1M Buy
144,245
+123,618
+599% +$3.82M 0.01% 507
2017
Q1 		$487K Sell
20,627
-472
-2% -$9.35K ﹤0.01% 609
2016
Q4 		$282K Sell
21,099
-3,212
-13% -$51.9K ﹤0.01% 744
2016
Q3 		$451K Buy
+24,311
New +$428K ﹤0.01% 615
2015
Q1 		– Sell
-1,066,572
Closed -$29.3M – 722
2014
Q4 		$29.3M Buy
+1,066,572
New +$26M 0.03% 403
2014
Q2 		– Sell
-126,273
Closed -$1.79M – 729
2014
Q1 		$1.79M Buy
126,273
+28,436
+29% +$384K ﹤0.01% 594
2013
Q4 		$1.14M Sell
97,837
-2,397,431
-96% -$27.5M ﹤0.01% 599
2013
Q3 		$29.5M Buy
2,495,268
+91,302
+4% +$1.17M 0.03% 392
2013
Q2 		$33.4M Buy
+2,403,966
New +$26.1M 0.04% 354

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Jennison Associates's EXAS Position: Q4 2025 in Review

Jennison Associates sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 306,196 shares — an estimated $16.8M sold.

Jennison Associates first reported a position in EXAS in Q2 2013 and held it in 34 quarters. The position peaked at $520M in Q4 2019. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Jennison Associates reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Jennison Associates sold 306,196 Exact Sciences shares in Q4 2025, an estimated $16.8M.
  • Jennison Associates first reported a position in Exact Sciences in Q2 2013 and held it in 34 quarters.
  • Jennison Associates's Exact Sciences position peaked at $520M in Q4 2019.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Jennison Associates's 13F filing for Q4 2025, filed 30 Jan 2026.